Not to be sneezed at: cardiovascular disease after COVID-19 infection

COVID-19 has changed our way of life since it was first identified in December of 2019. While our understanding of the manifestations and outcomes of the immediate acute illness has improved, we are still learning about the medium to long-term impact of this diagnosis on patients’ health. For some time, it has been suggested that COVID-19 may be associated with incident cardiovascular events such as venous thromboembolism, stroke and myocardial infarction.1 However, the absolute risk of these events and whether an excess risk is present are challenging to determine without a contemporary reference population. This is particularly problematic in the midst of a global pandemic. The UK Biobank is a large robust contemporary cohort of middle-aged volunteers who were prospectively recruited between 2006 and 2010.2 In this cohort, half a million participants aged between 40 and 69 years provided informed consent for detailed clinical assessment,...
Source: Heart - Category: Cardiology Authors: Tags: Press releases, COVID-19 Editorials Source Type: research